Authors: ROSELL R CARDENAL F MONTES A ARTAL A CARRATO A LOMAS M ALBEROLA V BARNETTO I MASSUTI B LIEPA AM

Citation: R. Rosell et al., QUALITY-OF-LIFE IN NONSMALL CELL LUNG-CANCER PATIENTS RECEIVING GEMCITABINE (GEMZAR(R)) PLUS CISPLATIN OR ETOPOSIDE PLUS CISPLATIN, Annals of oncology, 9, 1998, pp. 403-403

Authors: LIEPA AM PICUS J BLANKE C JOHN W CLARK J SCHULMAN L BURRIS A THORNTON D LOEHRER PJ

Citation: Am. Liepa et al., QUALITY-OF-LIFE ASSESSMENTS OF PATIENTS WITH PANCREATIC-CANCER RECEIVING MTA (LY231514, A MULTITARGETED ANTIFOLATE), European journal of cancer, 33, 1997, pp. 19-19

Authors: ANTON A CARRATO A GONZALEZLARRIBA JL VADEL C MASUTTI B MONTALAR J ARANDA E LIEPA AM

Citation: A. Anton et al., QUALITY-OF-LIFE ASSESSMENTS OF PATIENTS WITH NONSMALL FELL LUNG-CANCER RECEIVING GEMCITABINE (GEMZAR(TM)) AND CISPLATIN, European journal of cancer, 33, 1997, pp. 43-43

Authors: MINSHALL ME LIEPA AM

Citation: Me. Minshall et Am. Liepa, A REVIEW OF THE PHARMACOECONOMIC RESEARCH ON GEMCITABINE (GEMZAR(TM))IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 48-48